Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
-
- Clinical and Experimental Pediatrics
- /
- v.56 no.11
- /
- pp.490-495
- /
- 2013